The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
$ 9.50 · 4.9 (439) · In stock
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
Unique Genetic Characteristics and Clinical Prognosis of Female
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
Combinatorial tumor suppressor inactivation efficiently initiates
Oncogenic driver mutations in non-small cell lung cancer: Past
AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research
Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer, World Journal of Surgical Oncology
Combinatorial tumor suppressor inactivation efficiently initiates